Suchergebnisse - "Heiss, Brian L."

PubPharm (19)

11

TOCILIZUMAB FOR THE TREATMENT OF VIRAL INFECTIONS

enthalten in: Europäisches Patentamt | 2021

von RATAIN MARK J | STROHBEHN GARTH W | REID PANKTI D | +1

12

COVIDOSE : A Phase II Clinical Trial of Low-Dose Tocilizumab in the Treatment of Noncritical COVID-19 Pneumonia

enthalten in: Clinical pharmacology and therapeutics | 2021

von Strohbehn, G. | Heiss, B. | Rouhani, S. | +20

UpdateOf: medRxiv. 2020 Jul 26;:. - PMID 32743594

13

COVIDOSE : A Phase II Clinical Trial of Low‐Dose Tocilizumab in the Treatment of Noncritical COVID‐19 Pneumonia

enthalten in: Clinical Pharmacology & Therapeutics | 2021

von Strohbehn, G. | Heiss, B. | Rouhani, S. | +20

14

COVIDOSE : Low-dose tocilizumab in the treatment of Covid-19

enthalten in: medRxiv : the preprint server for health sciences | 2020

von Strohbehn, G. | Heiss, B. | Rouhani, S. | +20

UpdateIn: Clin Pharmacol Ther. 2020 Nov 18;:. - PMID 33210302

15

Trastuzumab-induced cardiomyopathy : incidence and associated risk factors in an inner-city population

enthalten in: Journal of cardiac failure | 2014

von Baron, K. | Brown, J. | Heiss, B. | +4

16

Trastuzumab-Induced Cardiomyopathy: Incidence and Associated Risk Factors in an Inner-City Population

enthalten in: Journal of cardiac failure | 2014

von Baron, K. | Brown, J. | Heiss, B. | +4

17

MicroRNA Targeting of Neurotropic Flavivirus: Effective Control of Virus Escape and Reversion to Neurovirulent Phenotype

enthalten in: Journal of virology | 2012

von Heiss, B. | Maximova, O. | Thach, D. | +2

18

MicroRNA targeting of neurotropic flavivirus : effective control of virus escape and reversion to neurovirulent phenotype

enthalten in: Journal of virology | 2012

von Heiss, B. | Maximova, O. | Thach, D. | +2

19

Insertion of microRNA targets into the flavivirus genome alters its highly neurovirulent phenotype

enthalten in: Journal of virology | 2011

von Heiss, B. | Maximova, O. | Pletnev, A.